Third-Party Hardware Modification of Interventional X-Ray Equipment
The newAdvaMed® Imaging® technical white paper outlines concerns with third-party modification of interventional X-ray equipment, which can pose unforeseen risks for patients and providers. The white paper further calls for a complete technical assessment before using any third-party modification to mitigate potential harm.
This report provides our recommendations to regulators and other policy makers and stakeholders regarding third-party hardware modifications. Download the full white paper here.
Related Reading
Event / Medical Imaging
Inside AdvaMed’s Standards Program: Building Consensus, Driving Innovation
On Demand
Learn how AdvaMed’s standards are shaping innovation and improving regulatory efficiency across the medical technology industry.
News / Diagnostics / Health Access / Medical Imaging
AdvaMed® Announces Opening Nominations for its 2026 Lifetime Achievement, Dx Lifetime of Leadership & Service, and theAdvaMed® Imaging Röntgen Awards
March 4, 2026
WASHINGTON—AdvaMed® announced today that nominations for its 2025 Lifetime Achievement Award as well as the AdvaMedDx Lifetime of Leadership & Service Award and theAdvaMed® Imaging Röntgen Award are open through April 10. All three of these annual awards will be presented during The MedTech Conference, Oct.18-21, 2026, in Boston.
News / Diagnostics / Medical Imaging
Perimeter Medical Imaging AI’s ‘Claire’ Becomes First FDA-approved AI-Enabled Imaging Device for Breast Cancer Surgery
March 3, 2026
TORONTO and DALLAS, March 3, 2026 /PRNewswire/ – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (“Perimeter” or the “Company”), a commercial-stage medical technology company, announced today that it has received U.S. Food and Drug Administration (“FDA”) premarket approval (“PMA”) for Claire™ (formerly the Perimeter OCT B-Series with ImgAssist AI 2.0), the first AI-enabled imaging device approved in the United States for intraoperative breast cancer margin assessment. The technology received Breakthrough Device designation from the FDA and is designed to enhance surgeons’ ability to detect difficult-to-see cancer during breast-conserving surgery and potentially reduce the need for re-operations.
News / Diagnostics / Digital Health / Medical Imaging / Regulatory Affairs
AdvaMed® Receives RAPS Accreditation for Medical Device Submissions Workshop Series (February 2026 in Washington, D.C.)
February 4, 2026
WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medical technology innovators, announced that its Medical Device Submissions Workshop Series (February 23-27 in Washington, D.C.) has been officially approved for RAC recertification credits by the Regulatory Affairs Professionals Society (RAPS).
Blog / Artificial Intelligence (AI) / Coverage & Payment / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access / Medical Imaging
Why the Health Tech Investment Act Matters: Peter Weems Breaks Down What This Means for Patients
January 26, 2026
In a new video developed in partnership with Patients Rising, AdvaMed’s Peter Weems, Vice President of Imaging Government Affairs and Policy Strategy, explains why the Health Tech Investment Act is critical to expanding patient access to FDA-authorized AI-enabled medical devices.
News / Artificial Intelligence (AI) / Coverage & Payment / Diagnostics / Digital Health / Government & Legislative Affairs / Medical Imaging / Regulatory Affairs
Medical Imaging Division Announces Rich Fabian as New Board Chair
January 16, 2026
WASHINGTON, D.C.—AdvaMed, the MedTech Association®, today announced that Rich Fabian, president and CEO of FUJIFILM Sonosite, will serve as the chair of the Medical Imaging division’s board of directors. He will succeed David Pacitti, CEO of Avanos Medical and former president and head of the Americas at Siemens Healthineers, the inaugural division board chair.
News / Artificial Intelligence (AI) / Coverage & Payment / Diagnostics / Digital Health / Government & Legislative Affairs / Medical Imaging / Orthopedic / Regulatory Affairs / Small Business
Mick Farrell, Chairman and CEO of Resmed, Named Chair ofAdvaMed® Board of Directors
December 11, 2025
WASHINGTON, D.C.—AdvaMed, the MedTech Association®, today announced Michael “Mick” Farrell, chairman and CEO of Resmed Inc. (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, will be the next chair of theAdvaMed® Board of Directors. Farrell will serve a two-year term beginning in January 2026.
News / Medical Imaging
AdvaMed® Releases White Paper on Medical Imaging Cybersecurity
August 7, 2025
WASHINGTON, DC—AdvaMed, the MedTech Association®, recently published a technical performance and safety white paper titled “Medical Imaging Device Cybersecurity: Critical Outage Situations and Response.” The white paper outlines common imaging device outage scenarios and manufacturers’ recommended steps for hospitals and radiology departments to consider in order to both mitigate the cyberattack’s impact and keep medical imaging systems functioning for physicians and patients.